ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery.

Phage display Protein A filtration human albumin lysozyme next-generation sequencing semisynthetic libraries tumor necrosis factor

Journal

mAbs
ISSN: 1942-0870
Titre abrégé: MAbs
Pays: United States
ID NLM: 101479829

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 22 1 2019
medline: 9 8 2019
entrez: 22 1 2019
Statut: ppublish

Résumé

We describe here the design, construction and validation of ALTHEA Gold Libraries™. These single-chain variable fragment (scFv), semisynthetic libraries are built on synthetic human well-known IGHV and IGKV germline genes combined with natural human complementarity-determining region (CDR)-H3/J

Identifiants

pubmed: 30663541
doi: 10.1080/19420862.2019.1571879
pmc: PMC6512909
doi:

Substances chimiques

Complementarity Determining Regions 0
Immunoglobulin G 0
Single-Chain Antibodies 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

516-531

Références

J Biol Chem. 1999 Jun 25;274(26):18218-30
pubmed: 10373423
J Mol Biol. 2000 Feb 11;296(1):57-86
pubmed: 10656818
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5399-404
pubmed: 10805799
Methods Mol Biol. 2004;248:161-76
pubmed: 14970495
Nat Biotechnol. 2004 Sep;22(9):1161-5
pubmed: 15300256
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3581-5
pubmed: 1565654
Nat Biotechnol. 2005 Mar;23(3):344-8
pubmed: 15723048
Methods. 2005 May;36(1):35-42
pubmed: 15848073
J Mol Biol. 2006 Mar 17;357(1):100-14
pubmed: 16413576
J Mol Recognit. 2006 Sep-Oct;19(5):413-22
pubmed: 16881059
Science. 1990 Jul 27;249(4967):386-90
pubmed: 1696028
J Biol Chem. 1992 Feb 5;267(4):2234-9
pubmed: 1733930
J Mol Biol. 1991 Dec 5;222(3):581-97
pubmed: 1748994
J Mol Biol. 2008 Feb 29;376(4):926-31
pubmed: 18199455
J Mol Biol. 2008 May 2;378(3):622-33
pubmed: 18384812
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20216-21
pubmed: 19875695
J Mol Biol. 1991 Jan 5;217(1):133-51
pubmed: 1988675
J Mol Biol. 2010 Mar 26;397(2):385-96
pubmed: 20114051
J Phys Chem B. 2010 May 20;114(19):6614-24
pubmed: 20411962
PLoS One. 2011;6(8):e22365
pubmed: 21829618
Methods Mol Biol. 2012;841:321-49
pubmed: 22222459
J Mol Recognit. 2012 Mar;25(3):103-13
pubmed: 22407974
Nature. 1990 Dec 6;348(6301):552-4
pubmed: 2247164
Mol Immunol. 2012 Jun;51(2):227-33
pubmed: 22487721
Protein Eng Des Sel. 2012 Oct;25(10):531-7
pubmed: 22915597
Front Immunol. 2012 Nov 15;3:342
pubmed: 23162556
Protein Eng Des Sel. 2013 Oct;26(10):683-93
pubmed: 23966567
FEBS Lett. 2014 Jan 21;588(2):269-77
pubmed: 24291820
Science. 2014 Feb 7;343(6171):656-661
pubmed: 24503852
Proteins. 2014 Aug;82(8):1553-62
pubmed: 24668560
MAbs. 2015;7(1):42-52
pubmed: 25484041
Clin Exp Immunol. 2016 Jan;183(1):50-6
pubmed: 26332693
MAbs. 2016 Aug-Sep;8(6):1045-63
pubmed: 27210805
MAbs. 2016 Oct;8(7):1336-1346
pubmed: 27315033
MAbs. 2016 Oct;8(7):1177-1194
pubmed: 27416017
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):944-949
pubmed: 28096333
Protein Cell. 2018 Jan;9(1):86-120
pubmed: 28822103
Front Immunol. 2018 Jan 04;8:1751
pubmed: 29379493
Curr Rheumatol Rep. 2018 Aug 9;20(10):57
pubmed: 30094742
Science. 1985 Jun 14;228(4705):1315-7
pubmed: 4001944
J Mol Biol. 1995 Dec 1;254(3):497-504
pubmed: 7490765
EMBO J. 1994 Jul 15;13(14):3245-60
pubmed: 8045255
J Exp Med. 1993 Jul 1;178(1):331-6
pubmed: 8315388
Nat Biotechnol. 1996 Mar;14(3):309-14
pubmed: 9630891
J Mol Biol. 1999 Feb 5;285(5):2177-98
pubmed: 9925793

Auteurs

Philippe Valadon (P)

a Antibody Design Labs , San Diego , CA , USA.

Sonia M Pérez-Tapia (SM)

b UDIBI, ENCB, Instituto Politécnico Nacional , México , México.

Renae S Nelson (RS)

a Antibody Design Labs , San Diego , CA , USA.

Omar U Guzmán-Bringas (OU)

b UDIBI, ENCB, Instituto Politécnico Nacional , México , México.

Hugo I Arrieta-Oliva (HI)

b UDIBI, ENCB, Instituto Politécnico Nacional , México , México.

Keyla M Gómez-Castellano (KM)

b UDIBI, ENCB, Instituto Politécnico Nacional , México , México.

Mary Ann Pohl (MA)

c Tri-Institutional Therapeutics Discovery Institute , New York , NY , USA.

Juan C Almagro (JC)

d GlobalBio, Inc ., Cambridge , MA , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH